Celyad Oncology Market Cap

Celyad Oncology has a market cap or net worth of €14.23 million as of April 28, 2026. Its market cap has decreased by -27.82% in one year.

Market Cap

14.23M

Enterprise Value

12.53M

Revenue

21.00K

Ranking

n/a

PE Ratio

17.67

Stock Price

€0.32

Market Cap Chart

Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 14.23M, a decrease of -86.04%. That is a compound annual growth rate of -14.24%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	13.52M	77.65%
Dec 31, 2025	7.61M	-74.20%
Dec 31, 2024	29.50M	82.56%
Dec 29, 2023	16.16M	41.33%
Dec 30, 2022	11.43M	-85.60%
Dec 31, 2021	79.42M	-13.96%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
European Medical Solutions	21.16M
BioSenic	1.44M
Hyloris Pharmaceuticals	149.52M
Onward Medical	200.59M
Oxurion NV	354.77K
Financière de Tubize	9.00B
argenx SE	42.11B
UCB SA	45.29B

Market Cap Rankings